Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric phase I/II study of entrectinib for NTRK/ROS1 fusion-positive solid tumors and primary CNS tumors
CTR20201930Phase 2Active
- Sponsor
- Roche
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entrectinib in Nonhematologic neoplasms, central nervous system tumor, sponsored by Roche. Started Apr 2021; status: active.
02
Drugs
entrectinib
03
Conditions
Nonhematologic neoplasmscentral nervous system tumor
Beyond the preview
Go deeper on CTR20201930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201930.